ENSTILAR (LEO Pharma Inc.)
Welcome to the PulseAid listing for the ENSTILAR drug offered from LEO Pharma Inc.. This Vitamin D [Chemical/Ingredient],Vitamin D Analog [EPC],Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | LEO Pharma Inc. |
NON-PROPRIETARY NAME: | calcipotriene and betamethasone dipropionate |
SUBSTANCE NAME: | CALCIPOTRIENE HYDRATE; BETAMETHASONE DIPROPIONATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Vitamin D [Chemical/Ingredient],Vitamin D Analog [EPC],Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |
ROUTE: | TOPICAL |
DOSAGE FORM: | AEROSOL, FOAM |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2015-10-16 |
END MARKETING DATE: | 0000-00-00 |
ENSTILAR HUMAN PRESCRIPTION DRUG Details:
Item Description | ENSTILAR from LEO Pharma Inc. |
LABELER NAME: | LEO Pharma Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 50; .5(ug/g; mg/g) |
START MARKETING DATE: | 2015-10-16 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 50222-302_3bd49f56-f110-492e-b95a-a7461711769e |
PRODUCT NDC: | 50222-302 |
APPLICATION NUMBER: | NDA207589 |
Other CALCIPOTRIENE HYDRATE; BETAMETHASONE DIPROPIONATE Pharmaceutical Manufacturers / Labelers: